title: Phosphorylation, Signaling, and Cancer: Targets and Targeting.
authors.affiliation: Cellular Signaling Unit, Department of Surgery, Medicine, Dentistry and Morphology, University of Modena and Reggio Emilia, Largo del Pozzo, 71-41100 Modena, Italy.
authors.forename: Sandra
authors.initials: S
authors.lastname: Marmiroli
authors.affiliation: Piqur Therapeutics, Hochbergerstrasse 60C, 4057 Basel, Switzerland.
authors.forename: Doriano
authors.initials: D
authors.lastname: Fabbro
authors.affiliation: Department of Cell and Developmental Biology, Kyoto University, Kitashirakawa, Oiwake-cho, Sakyo-ku, Kyoto 606-8502, Japan.
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Miyata
authors.affiliation: Center for Applied Proteomics and Molecular Medicine, George Mason University, 10920 George Mason Circle, Manassas, VA 20110, USA.
authors.forename: Mariaelena
authors.initials: M
authors.lastname: Pierobon
authors.affiliation: Department of Biomedical Sciences, University of Padova, Via U. Bassi 58/b, 35131 Padova, Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Ruzzene
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006801:Humans; D058990:Molecular Targeted Therapy / Q000379:methods*; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D010770:Phosphotransferases / Q000378:metabolism*; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D015398:Signal Transduction / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D010770:Phosphotransferases